Cargando…

In Vitro and in Vivo Effects of Nitrofurantoin on Experimental Toxoplasmosis

Toxoplasma gondii is an important opportunistic pathogen that causes toxoplasmosis, which has very few therapeutic treatment options. The most effective therapy is a combination of pyrimethamine and sulfadiazine; however, their utility is limited because of drug toxicity and serious side effects. Fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeo, Seon-Ju, Jin, ChunMei, Kim, SungYeon, Park, Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Parasitology and Tropical Medicine 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870977/ https://www.ncbi.nlm.nih.gov/pubmed/27180573 http://dx.doi.org/10.3347/kjp.2016.54.2.155

Ejemplares similares

In Vitro and In Vivo Trypanocidal Efficacy of Synthesized Nitrofurantoin Analogs
por: Munsimbwe, Linous, et al.
Publicado: (2021)

Assessment of Nitrofurantoin as an Experimental Intracanal Medicament in Endodontics
por: Alrahman, Mewan Salahalddin A., et al.
Publicado: (2020)

Melanogenesis inhibitory effect of aerial part of Pueraria thunbergiana in vitro and in vivo
por: Han, EunByeol, et al.
Publicado: (2014)

Reproductive toxicology. Nitrofurantoin.
Publicado: (1997)

Relapsing nitrofurantoin-induced pneumonitis
por: Turner, Richard D., et al.
Publicado: (2011)

Mechanisms of oxidative stress-induced in vivo mutagenicity by potassium bromate and nitrofurantoin
por: Tsuchiya, Takuma, et al.
Publicado: (2018)

Auranofin Is Highly Efficacious against Toxoplasma gondii In Vitro and in an In Vivo Experimental Model of Acute Toxoplasmosis
por: Andrade, Rosa M., et al.
Publicado: (2014)

In vitro and in vivo anti−Toxoplasma activities of HDAC inhibitor Panobinostat on experimental acute ocular toxoplasmosis
por: Zhang, Yu, et al.
Publicado: (2022)

Nitrofurantoin‐induced acute pulmonary toxicity
por: Livanios, Konstantinos, et al.
Publicado: (2016)

Nitrofurantoin methanol monosolvate
por: Vangala, Venu R., et al.
Publicado: (2011)

Nitrofurantoin induced interstitial lung disease
por: Naidu, G. D., et al.
Publicado: (2014)

Nitrofurantoin-induced radiation recall dermatitis
por: Garrahy, Ian, et al.
Publicado: (2019)

Synthesis, in vitro Antileishmanial Efficacy and Hit/Lead Identification of Nitrofurantoin‐Triazole Hybrids
por: Zuma, Nonkululeko H., et al.
Publicado: (2022)

The ethanolic extract of the fungus Trichoderma stromaticum decreases the Toxoplasma gondii replication in vitro and ameliorates the experimental toxoplasmosis in vivo
por: Nascimento, Layane Alencar Costa, et al.
Publicado: (2022)

Consider Nitrofurantoin as a Cause of Lung Injury
por: Almeida, Paulo, et al.
Publicado: (2019)

Molecular mechanisms of collateral sensitivity to the antibiotic nitrofurantoin
por: Roemhild, Roderich, et al.
Publicado: (2020)

Systemic Inflammatory Response Syndrome Secondary to Nitrofurantoin
por: McGarry, Molly R., et al.
Publicado: (2021)

Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis
por: Anupama, B. K., et al.
Publicado: (2021)

Nitrofurantoin: Interstitial lung disease: case report
Publicado: (2021)

Nitrofurantoin: what is the evidence for current UK guidance?
por: Kashouris, Eleanor, et al.
Publicado: (2023)

Combined Effect of Nitrofurantoin and Plant Surfactant on Bacteria Phospholipid Membrane
por: Rojewska, Monika, et al.
Publicado: (2020)

Nitrofurantoin-induced pulmonary fibrosis: a case report
por: Goemaere, Natascha NT, et al.
Publicado: (2008)

Autoimmune hepatitis triggered by nitrofurantoin: a case series
por: Appleyard, Sally, et al.
Publicado: (2010)

Nitrofurantoin Toxicity: A Near Case of Mistaken Identity
por: Miskoff, Jeffrey A, et al.
Publicado: (2018)

Nitrofurantoin—Microbial Degradation and Interactions with Environmental Bacterial Strains
por: Pacholak, Amanda, et al.
Publicado: (2019)

Fosfomycin versus Nitrofurantoin for the Treatment of Lower UTI in Outpatients
por: Sharma, Shraddha, et al.
Publicado: (2021)

Drug-induced haemolysis: another reason to be cautious with nitrofurantoin
por: Bhatt, Chaitanya, et al.
Publicado: (2023)

Nitrofurantoin-Induced Exfoliative Dermatitis: A Case Report
por: Morna, Carolina, et al.
Publicado: (2022)

O02 Nitrofurantoin: what is the evidence for current guidance?
por: Kashouris, Eleanor, et al.
Publicado: (2023)

Chondroprotective Effects of Wogonin in Experimental Models of Osteoarthritis in vitro and in vivo
por: Park, Jin Sung, et al.
Publicado: (2015)

Susceptibility of Escherichia coli from Community-Acquired Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and Temocillin in Korea
por: Seo, Mi-Ran, et al.
Publicado: (2014)

Effect of Sub-Inhibitory Concentrations of Nitrofurantoin, Ciprofloxacin, and Trimethoprim on In Vitro Biofilm Formation in Uropathogenic Escherichia coli (UPEC)
por: Whelan, Shane, et al.
Publicado: (2022)

Nitrofuran Derivatives Cross-Resistance Evidence—Uropathogenic Escherichia coli Nitrofurantoin and Furazidin In Vitro Susceptibility Testing
por: Bielec, Filip, et al.
Publicado: (2023)

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin
por: Singh, Jitendra, et al.
Publicado: (2016)

Pleural effusion: An uncommon manifestation of nitrofurantoin-induced pulmonary injury
por: Davis, Jared W., et al.
Publicado: (2016)

An assessment of the role of redox cycling in mediating the toxicity of paraquat and nitrofurantoin.
por: Adam, A, et al.
Publicado: (1990)

Respiratory arrest due to nitrofurantoin treatment in the absence of pulmonary pathology
por: Çoban, Hikmet
Publicado: (2015)

Genomic insights into nitrofurantoin resistance mechanisms and epidemiology in clinical Enterobacteriaceae
por: Osei Sekyere, John
Publicado: (2018)

A rare case of nitrofurantoin‐induced acute lung injury
por: Karmali, Rehan, et al.
Publicado: (2020)

Nitrofurantoin Failure in Elderly Men: A Retrospective Observational Study
por: Wolterink, Ilse, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ct1ou25he5fl1kkooigfo2vip6